Wikidata

(Q62812985)

English

RCT Comparing Autologous Hematopoietic Stem Cell Transplantation Versus Alemtuzumab in MS

clinical trial

In more languages

Statements

short name
RAM-MS (English)
0 references
title
Randomized Autologous Hematopoietic Stem Cell Transplantation Versus Alemtuzumab for Patients With Relapsing Remitting Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Denmark
0 references
Netherlands
0 references
Norway
0 references
Sweden
0 references
start time
21 March 2018
0 references
end time
21 March 2022
0 references
number of participants
100
0 references
research intervention
(RS)-cyclophosphamide
0 references
alemtuzumab
0 references
lenograstim
0 references
minimum age
18 year
0 references
maximum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62812985&oldid=1857074642"